Cardiac Science Chief Operating Officer Dave Marver has been named the medical device company's president and CEO, replacing John Hinson, who is resigning "for personal reasons."
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan